Moderna, Inc. (MRNA)
46.66
-0.64
(-1.34%)
USD |
NASDAQ |
May 05, 16:00
46.52
-0.14
(-0.31%)
After-Hours: 19:05
Moderna Free Cash Flow : -1.603B for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Amgen, Inc. | 8.597B |
| Gilead Sciences, Inc. | 9.456B |
| Johnson & Johnson | 17.80B |
| Eli Lilly & Co. | 10.37B |
| Arbutus Biopharma Corp. | -39.72M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -630.00M |
| Cash from Investing (Quarterly) | -76.00M |
| Cash from Financing (Quarterly) | 17.00M |
| Free Cash Flow Per Share (Quarterly) | -1.752 |
| Free Cash Flow to Equity (Quarterly) | -685.00M |
| Free Cash Flow to Firm (Quarterly) | -674.89M |
| Free Cash Flow Yield | -8.78% |